CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma

NCT03118180 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhejiang University

Collaborators